1157 related articles for article (PubMed ID: 11161575)
1. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
Kisanuki YY; Hammer RE; Miyazaki J; Williams SC; Richardson JA; Yanagisawa M
Dev Biol; 2001 Feb; 230(2):230-42. PubMed ID: 11161575
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell-specific expression of Cre recombinase in transgenic mice.
Li WL; Cheng X; Tan XH; Zhang JS; Sun YS; Chen L; Yang X
Yi Chuan Xue Bao; 2005 Sep; 32(9):909-15. PubMed ID: 16201233
[TBL] [Abstract][Full Text] [Related]
3. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice.
Yamauchi Y; Abe K; Mantani A; Hitoshi Y; Suzuki M; Osuzu F; Kuratani S; Yamamura K
Dev Biol; 1999 Aug; 212(1):191-203. PubMed ID: 10419695
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
Licht AH; Raab S; Hofmann U; Breier G
Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
[TBL] [Abstract][Full Text] [Related]
5. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
Dacquin R; Starbuck M; Schinke T; Karsenty G
Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the fate of Sry-expressing cells using an in vivo Cre/loxP system.
Ito M; Yokouchi K; Yoshida K; Kano K; Naito K; Miyazaki J; Tojo H
Dev Growth Differ; 2006 Jan; 48(1):41-7. PubMed ID: 16466392
[TBL] [Abstract][Full Text] [Related]
7. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
[TBL] [Abstract][Full Text] [Related]
8. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
[TBL] [Abstract][Full Text] [Related]
9. New approach to cell lineage analysis in mammals using the Cre-loxP system.
Sato M; Yasuoka Y; Kodama H; Watanabe T; Miyazaki JI; Kimura M
Mol Reprod Dev; 2000 May; 56(1):34-44. PubMed ID: 10737965
[TBL] [Abstract][Full Text] [Related]
10. Lineage and morphogenetic analysis of the cardiac valves.
de Lange FJ; Moorman AF; Anderson RH; Männer J; Soufan AT; de Gier-de Vries C; Schneider MD; Webb S; van den Hoff MJ; Christoffels VM
Circ Res; 2004 Sep; 95(6):645-54. PubMed ID: 15297379
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart.
Zhou B; Wu B; Tompkins KL; Boyer KL; Grindley JC; Baldwin HS
Development; 2005 Mar; 132(5):1137-46. PubMed ID: 15689382
[TBL] [Abstract][Full Text] [Related]
12. Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues.
Liu F; Woitge HW; Braut A; Kronenberg MS; Lichtler AC; Mina M; Kream BE
Int J Dev Biol; 2004 Sep; 48(7):645-53. PubMed ID: 15470637
[TBL] [Abstract][Full Text] [Related]
13. VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages.
Georgiades P; Ogilvy S; Duval H; Licence DR; Charnock-Jones DS; Smith SK; Print CG
Genesis; 2002 Dec; 34(4):251-6. PubMed ID: 12434335
[TBL] [Abstract][Full Text] [Related]
14. Cre recombinase-mediated gene targeting of mesenchymal cells.
Florin L; Alter H; Gröne HJ; Szabowski A; Schütz G; Angel P
Genesis; 2004 Mar; 38(3):139-44. PubMed ID: 15048811
[TBL] [Abstract][Full Text] [Related]
15. Smooth muscle expression of Cre recombinase and eGFP in transgenic mice.
Xin HB; Deng KY; Rishniw M; Ji G; Kotlikoff MI
Physiol Genomics; 2002 Sep; 10(3):211-5. PubMed ID: 12209023
[TBL] [Abstract][Full Text] [Related]
16. MyoD-cre transgenic mice: a model for conditional mutagenesis and lineage tracing of skeletal muscle.
Chen JC; Mortimer J; Marley J; Goldhamer DJ
Genesis; 2005 Mar; 41(3):116-21. PubMed ID: 15729689
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
Jin C; McKeehan K; Wang F
Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
[TBL] [Abstract][Full Text] [Related]
18. Efficient recombination in pancreatic islets by a tamoxifen-inducible Cre-recombinase.
Zhang H; Fujitani Y; Wright CV; Gannon M
Genesis; 2005 Jul; 42(3):210-7. PubMed ID: 15986486
[TBL] [Abstract][Full Text] [Related]
19. Utility of HoxB2 enhancer-mediated Cre activity for functional studies in the developing inner ear.
Szeto IY; Leung KK; Sham MH; Cheah KS
Genesis; 2009 Jun; 47(6):361-5. PubMed ID: 19370753
[TBL] [Abstract][Full Text] [Related]
20. Site- and time-specific gene targeting in the mouse.
Metzger D; Chambon P
Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
